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BACKGROUND: Testicular germ cell tumours (TGCT) are thought to originate from fetal germ cells that fail to
differentiate normally, but no animal model for these events has been described. We evaluated the marmoset
(Callithrix jacchus) as a model by comparing perinatal germ cell differentiation with that in humans. METHODS:
Immunohistochemical proﬁling was used to investigate germ cell differentiation (OCT4, NANOG, AP-2g,M A G E - A 4 ,
VASA, NANOS-1) and proliferation (Ki67) in fetal and neonatal marmoset testes in comparison with the human
and, to a lesser extent, the rat. RESULTS: In marmosets and humans, differentiation of gonocytes into spermatogonia
is associated with the gradual loss of pluripotency markers such as OCT4 and NANOG, and the expression of germ
cell-speciﬁc proteins such as VASA. This differentiation occurs asynchronously within individual cords during fetal
and early postnatal life. This contrasts with rapid and synchronous germ cell differentiation within and between
cords in the rat. Similarly, germ cell proliferation in the marmoset and human occurs throughout perinatal life, in
contrast to rats in which proliferation ceases during this period. CONCLUSIONS: The marmoset provides a good
model for normal human germ cell differentiation and proliferation. The perinatal marmoset may be a useful
model in which to establish factors that lead to failure of normal germ cell differentiation and the origins of TGCT.
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Introduction
Male fertility depends on the daily production of millions of
sperm, and this is dependent upon the continuous, controlled
proliferation of spermatogonia. Spermatogonia develop from
relatively undifferentiated fetal germ cells (gonocytes), a
process that is initiated in fetal life (Fukuda et al., 1975), and
which involves loss of stem cell/embryonic cell characteristics
(Gaskell et al., 2004; Honecker et al., 2004). If differentiation
from a gonocyte to a spermatogonium does not occur, then
this cell cannot contribute to spermatogenesis in adulthood.
Additionally, persistence in the testis of an undifferentiated
fetal germ cell with stem cell-like characteristics is potentially
dangerous, as this is thought to be how carcinoma in situ (CIS)
cells arise in humans (Rajpert-De Meyts, 2006), and it is these
cells that ultimately give rise to testicular germ cell tumours
(TGCT) in young men (Skakkebaek et al., 2001). The inci-
dence of testicular cancer has increased progressively in
Western countries, and it has been proposed that as yet
unidentiﬁed environmental and lifestyle factors are responsible
for this increase (Skakkebaek et al., 2007). It is unknown what
perinatal factors might enable CIS cells to develop, and this
ignorance is due in large part to the lack of an animal model
in which to study the mechanistic origins of CIS/TGCT.
Rodent studies have provided some insight into the
maturation of the germ cell lineage in fetal/neonatal life
(Wilhelm et al., 2007), but their usefulness is limited as
neither CIS nor TGCT occur spontaneously, nor can be
induced, in the rodent testis. This could be due to inter-species
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Advance Access publication on August 11, 2008differences in testis and/or germ cell development, as there are
some fundamental differences in the ‘set-up’ of spermato-
genesis between rodents and humans. For example, compared
with the human, rodents exhibit a high efﬁciency of spermato-
genesisasevidencedbyalargegermcelltoSertolicellratioand
a high level of daily sperm production per unit weight of testis
(Sharpe, 1994), compared with some primates (Millar et al.,
2000; Sharpe et al., 2000) and humans (Clermont, 1963). The
‘segmental’arrangementofspermatogenicstagesinthesemini-
ferous tubules of rodents may be associated with more efﬁcient
spermatogenesis than the ‘mixed’ arrangement in the human. It
isthoughtthatthisdifferencemayitselfarisebecauseofthelow
number of spermatogonial mitoses that occur in the human
when compared with the rat and with other animals with a
segmental organization (Sharpe, 1994). Moreover, although
differentiation of gonocytes into spermatogonia occurs during
fetal life in both humans and rodents, the process appears less
organized in the human, with gonocytes still detectable in
early postnatal life. Evidence to support these conclusions has
been established using a battery of germ cell-speciﬁc protein
markers that enable sequential germ cell differentiation to be
visualized (Gaskell et al., 2004; Honecker et al., 2004;
Rajpert-De Meyts et al., 2004; Hoei-Hansen et al., 2005;
Anderson et al., 2007). Such ‘organizational’ differences in
germ cells might be a factor that predisposes towards develop-
ment of CIS cells in the human but not in the rodent.
Based on previous studies it has been proposed that the
common marmoset (Callithrix jacchus), a small New World
primate, could potentially provide a better animal model for
human germ cell development than rodents. In particular, the
marmoset has many similarities to the human in terms of
timing of testis development and function, in addition to the
subsequent organization and efﬁciency of spermatogenesis.
This includes a neonatal period of reproductive hormonal
activity (neonatal testosterone rise or ‘mini-puberty’) (Mann
and Fraser, 1996) followed by a period of ‘childhood’ quies-
cence (Kelnar et al., 2002) prior to the onset of puberty,
which does not occur in rodents (Plant 2006). Then in adult-
hood, similar to the human, there is a ‘mixed’ organization
of spermatogenic stages within the tubule, in contrast to
rodents and other primate models in which there is a ‘segmen-
tal’ organization of the spermatogenic stages (Millar et al.,
2000; Sharpe, 1994; Weinbauer et al., 2001). Additionally,
the germ cell to Sertoli cell ratio is low in the marmoset, as
in the human (Sharpe et al., 2000), indicating low efﬁciency
of spermatogenesis when compared with rodents. These simi-
larities led us to consider if the marmoset might also be a
better model than rodents in terms of fetal germ cell develop-
ment and differentiation, as this would have implications for
studies into the origins of CIS/TGCT. However, a detailed
analysis of testis development and germ cell maturation in
the fetal marmoset testis has not previously been reported.
Therefore the aim of the present study was to use a panel of
germ cell differentiation and proliferation markers previously
validated on human fetal testes (Gaskell et al., 2004; Honecker
et al., 2004; Rajpert-De Meyts et al., 2004; Hoei-Hansen et al.,
2005; Pauls et al., 2006; Anderson et al., 2007) to characterize
the timing and organization of germ cell differentiation in the
fetal and neonatal marmoset testis, and to undertake a direct
comparison with the human, and to a lesser extent with the rat.
Materials and Methods
Tissue collection
Marmoset testes
Testes were obtained from the fetuses of elderly pregnant marmosets
in the colony breeding stock that were being euthanized to make way
for younger breeding animals. Gestation in the marmoset lasts for
 20 weeks (144 days) (Windle et al., 1999). The gestation of pregnant
females was assessed by palpation and conﬁrmed by reference to pub-
lished crown rump length data (Chambers and Hearn, 1985). Mothers
and fetuses were euthanized by injection of an overdose of sodium
pentobarbitone (Euthatal; Rhone Merieux Ltd, Harlow, Essex, UK).
The fetuses (11 weeks, n ¼ 1; 14 weeks, n ¼ 2; 15 weeks, n ¼ 1;
16 weeks, n ¼ 2; 17 weeks, n ¼ 2; 20 weeks, n ¼ 2) were delivered
by hysterotomy. Fetuses were ﬁxed in Bouins for 6 h (larger fetuses
were partially dissected prior to ﬁxing) and then transferred to 70%
ethanol. Sections of postnatal testes (aged 1 day, and 2, 6, 22, 35 or
48 weeks, adult; n ¼ 3 for each age), were obtained from tissue
remaining from previous studies, in order to reduce the animal
numbers required (Kelnar et al., 2002; Sharpe et al., 2003), in addition
to testes from animals euthanized for colony management purposes.
All testes were ﬁxed as described above, prior to processing.
First and second trimester human fetal testes
Human fetal testes were obtained following termination of pregnancy
during the ﬁrst (8–10 weeks, n ¼ 4) or second trimester (14–19
weeks, n ¼ 9). Women gave consent in accordance with national
guidelines (Polkinghorne, 1989), and ethical approval was obtained
from the Local Research Ethics Committee. Termination was
induced with mifepristone (200 mg, orally), followed by misopristone
(Pharmacia, Surrey, UK, 200 mg every 3 h per vaginam). No termi-
nations were due to fetal abnormalities. In second trimester samples
gestational age was determined initially by ultrasound examination,
followed by direct measurement of foot length. The sex of ﬁrst trime-
ster samples was determined by PCR for the SRY gene as previously
described (Gaskell et al., 2004). Testes were ﬁxed for 2 h in Bouins
and then transferred into 70% ethanol prior to processing.
Third trimester and postnatal human testes
Third trimester (n ¼ 3) and postnatal human testes were obtained at
autopsy with consent of their legal guardian (courtesy of K.M.)
from boys who died from various causes (excluding reproductive
and endocrine abnormalities). Testes were ﬁxed in 10% neutral
buffered formalin for at least 24 h and processed as below.
Rat testes
Wistar rats were maintained in our own animal facility according to
U.K.Home Ofﬁceguidelines. Pregnant damswere killed by inhalation
of carbon dioxide when their fetuses had reached embryonic day 15.5
(e15.5, n ¼ 5) or e19.5 (n ¼ 5). Fetuses were removed, decapitated
and placed in ice-cold phosphate-buffered saline (PBS) (Sigma,
Poole, Dorset, UK). Testes were removed via microdissection and
ﬁxed for 1 h in Bouins followed by transfer into 70% ethanol.
Tissue processing
All ﬁxed testes were embedded in parafﬁn using standard processes
and sections of 5 mm thickness were prepared.
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Details of antibodies, dilutions and requirement for antigen retrieval
are shown in Table I. Sections were dewaxed in xylene, rehydrated
in graded alcohols and washed in tap water. Sections requiring
antigen retrieval were subjected to pressure cooking in 0.01 M
citrate (pH 6.0) buffer as described previously (Norton et al.,
1994). Sections were treated with 3% (v/v) H2O2 in methanol for
30 min and washed in water, followed by Tris-buffered saline (TBS,
0.05 M Tris and 0.85% NaCl, pH 7.6) for a further 5 min. Endo-
genous biotin was blocked using an avidin/biotin blocking kit
(Vector Laboratories Inc., Peterborough, UK), according to the man-
ufacturers instructions. Sections were incubated in appropriate
normal serum (diluted 1:5 with TBS containing 5% (w/v) bovine
serum albumin (BSA) (Sigma) for 30 min. Sections were incubated
overnight with primary antibody diluted in serum at 48C in a humidi-
ﬁed chamber. Sections were washed in TBS for two 5 min periods and
incubated for 30 min with the appropriate biotinylated secondary anti-
body (swine anti-rabbit, rabbit anti-mouse; both Dako, Cambridge-
shire, UK or rabbit anti-goat; Vector Laboratories Inc.), diluted in
normal serum. This was followed by two further 5 min washes in
TBS and incubation for 30 min with Streptavidin–horse-radish per-
oxidase at 1:1000 (Dako), diluted in TBS.
Visualization was performed using 3,3-diaminobenzidine tetrahy-
drochloride (Dako) and sections were counterstained with haemat-
oxylin, dehydrated in graded alcohols and immersed in xylene
before mounting in Pertex mounting medium (CellPath plc, Hemel
Hempstead, UK). For each experiment a negative control in which
the primary antibody had been replaced with the appropriate normal
serum was included. Images were captured using an Olympus
Provis microscope (Olympus Optical, London, UK) connected to a
Canon DS126131 camera and images obtained using Canon EOS
image capture software (Canon, Woodhatch, Surrey, UK).
For double immunohistochemistry, sections were stained for VASA
(an RNA-binding protein) using Streptavidin–Alkaline phosphatase
(Dako) at 1:400 for 30 min and visualization with 1 mg/ml Fast
Blue (Sigma) in fast blue buffer, until desired staining was achieved
(typically 10–15 min). Ki67 (marker of cell proliferation) primary
antibody was then applied and subsequent steps were as described
above for single immunostaining.
Immunoﬂuorescence
Sections were initially treated as described for single staining as far as the
primary antibody stage, with PBS (Sigma) washes between each step.
Antigen retrieval was required for all experiments and normal goat
(AP-2g, VASA and NANOS) or chicken (OCT4) serum (1:5 with
TBS and 5% BSA) was used for serum block and dilution of antibodies.
Details of antibodies and the visualization method are listed in Table II.
Following overnight incubation with primary antibody in goat
serum, sections were incubated with secondary antibody for 30 min,
followed by the ﬁrst visualization reagent. For this and subsequent
steps, the sections were kept in darkness. Sections were incubated
for 30 min in goat serum, followed by a second avidin/biotin block.
For NANOS-1 (an RNA binding protein) and VASA, rabbit immuno-
globulin G (Sigma) at 1:2000 was applied for 30 min, followed by
the second primary antibody in goat serum applied overnight at 48C.
Sections were incubated with secondaryantibody for 30 min, followed
by the second visualization reagent. To-pro-3 (Molecular Probes,
Leiden, Netherlands) was applied at 1:1000 in PBS for 5 min as a
nuclear counterstain and the slides were mounted using Permaﬂuor
(Immunotech, Marseille, France). Images were captured using an
LSM 510 Confocal microscope (Carl Zeiss, Hertfordshire, UK).
Germ cell proliferation index
Ki67 immunohistochemistry (as described above) was used to deter-
mine which germ cells were proliferating in the marmoset testis.
The fetal germ cells were identiﬁed based on morphology and position
within the seminiferous cords. Sections were counted independently
by two observers (R.M. and G.C.), to ensure accuracy of germ cell
identiﬁcation, while postnatal germ cells were identiﬁed using
VASA/Ki67 co-staining. Cells were counted using an objective
ﬁtted to an Olympus BH2 microscope with Hitachi HVC20 Camera
(Olympus Optical), and images were analysed using Image Pro-plus
version 4.5.1 with Stereology Pro 5.0 (Media Cybernetics, Woking-
ham, Berkshire, UK). Excellent agreement between the two observers
was found. The proliferation index was calculated by dividing the
number of Ki67-positive germ cells by the total number of germ
cells assessed in thirty randomly selected ﬁelds.
Results
Seminiferous cord structure and localization of cell types
within the testis of the marmoset during fetal life
Testes obtained from fetal marmosets from 11 weeks until term
all contained well-deﬁned testicular cords surrounded by an
Table I. Antibodies and conditions for immunohistochemistry in the testes.
Antigen Source Species Dilution Retrieval
AP-2g Santa Cruz
a Mouse 1:20 Y
OCT 4 Santa Cruz
a Goat 1:50 Y
NANOG RþD
b Goat 1:50 Y
VASA Abcam
c Rabbit 1:500 Y
MAGE-A4 Gift
d Mouse 1:20 N
NANOS-1 Abcam
c Rabbit 1:500 Y
AMH Santa Cruz
a Rabbit 1:500 N
3b-HSD Gift
e Rabbit 1:1000 N
Ki67 DAKO
f Mouse 1:40 Y
All antibodies were raised against human peptide sequences.
aSanta Cruz
Biotechnology, CA, USA;
bRþD Systems, MN, USA;
cAbcam, Cambridge,
UK;
dDr Guilio Spagoli, University Hospital, Basel, Switzerland;
eProf. Ian
Mason, The Queen’s Medical Research Institute, Edinburgh, UK;
fDAKO,
California, USA. OCT4 and AP-2g: transcription factors; NANOG:
homeobox domain protein; MAGE-A4: a cancer testis antigen; VASA and
NANOS-1: RNA-binding proteins; 3b-HSD: 3b-hydroxysteroid
dehydrogenase; Ki67: cell proliferation marker.
Table II. Antibodies and conditions used for immunoﬂuorescence.
Antigen 1 Dilution Secondary antibody Visualization Antigen 2 Dilution Secondary antibody Visualization
AP-2g 1:60 GAM-p
a Tyr-Cy3 (10 min)
d VASA 1:200 GAR-b Str-488
VASA 1:200 GAR(fab)-b
b Str-488 (1 h)
e NANOS 1:60 GAR(fab)-b Str-546
g
VASA 1:200 GAR-b
c Str-488 (1 h) OCT4 1:50 CAG-p
f Tyr-Cy3
aGAM-p, goat anti-mouse peroxidise;
bGAR(fab)-b, goat anti-rabbit biotinylated fab fragment;
cGAR-b, goat anti-rabbit biotinylated;
dTyr-Cy3,
tyramide-enhanced Cy3 (PerkinElmer, MA, USA);
eStr-488, streptavidin 488 (Molecular Probes);
fCAG-p, chicken anti-goat biotinylated;
gStr-546, streptavidin
546 (Molecular Probes).
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both histologically (small nuclei) and by the cytoplasmic
localization of anti-Mu ¨llerian hormone (AMH), which
was expressed in all the testes examined (Fig. 1). Germ cells
were identiﬁed within the cords, because their nuclei had a
larger diameter than the Sertoli cells, they expressed one or
more germ cell markers (see below) and they lacked expression
of AMH (Fig. 1). Within the interstitium, Leydig cells were
identiﬁed by expression of 3b-hydroxysteroid dehydrogenase
(Fig. 1). The general organization of the cell types within the
fetal marmoset testis was comparable to that described in the
human fetal testis (Gaskell et al., 2004).
Expression of markers of pluripotency and early germ cell
differentiation in the marmoset in perinatal life and
comparison with the human
Marmoset
Expression of the transcription factors AP-2g and OCT4,
and NANOG (a homeobox domain protein) was germ cell-
speciﬁc and was detected in a decreasing proportion of the
total germ cell population during progression through fetal
life into the early postnatal period (Fig. 2). All three proteins
were expressed in the majority of germ cells at 11 weeks’
gestation (not shown), but by the end of pregnancy the pro-
teins were only immunolocalized to a small subset of germ
cells. For NANOG, germ cell expression ceased between
2 and 6 weeks of postnatal age, while OCT4 and AP-2g
expression persisted in a few, scattered germ cells until
6 weeks postnatally (Fig. 2).
Human
Consistent with previous reports, OCT4 (Fig. 2), NANOG and
AP-2g (not shown) were detected in most testicular germ cells
of ﬁrst trimester fetuses but the proportion of immunopositive
germ cells decreased as gestation progressed (Looijenga et al.,
2003; Gaskell et al., 2004; Honecker et al., 2004; Rajpert-De
Meyts et al., 2004; Pauls et al., 2006; Kerr et al., 2008).
A few OCT4-positive germ cells were still present at 4
weeks postnatally (Fig. 2) and occasionally at 6 months after
birth (not shown) and similar results were obtained using the
anti-AP-2g antibody. NANOG was detected in occasional
germ cells at 4 weeks of postnatal age but not in tissue from
older individuals (not shown).
Expression of proteins associated with germ cell
differentiation in the perinatal marmoset and comparison
with the human
Marmoset
During fetal life there was an increase in the proportion of germ
cells that were immunopositive for MAGE-A4 (a cancer
testis antigen) and VASA as gestation progressed (Fig. 3). At
11 weeks of gestation none of the germ cells expressed
VASA or MAGE-A4 (not shown) but at 15 weeks a small
proportion of germ cells expressed these proteins within their
cytoplasm and by birth the majority of germ cells were positive
for VASA and similar results were obtained for MAGE-A4. By
6 weeks of postnatal age, only the occasional germ remained
negative for these proteins.
Human
Consistent with a previous study (Anderson et al., 2007), no
expression of VASA was detected in germ cells in testes in
the ﬁrst trimester (not shown), but VASA immunopositive
germ cells were detected in second trimester testes, with
increasing proportions of germ cells expressing VASA in the
third trimester (Fig. 3). In the early postnatal period almost
every testicular germ cell expressed VASA. A similar pattern
of expression was also found for MAGE-A4 (not shown).
Co-localization of germ cell markers demonstrates
asynchronous germ cell differentiation in the marmoset
and human, in contrast to the rat
We used co-localization studies to investigate the relationship
between germ cells expressing proteins previously localized to
Figure 1: General structure and organization of the fetal and early postnatal marmoset (Callithrix jacchus) testis as illustrated by immunoexpres-
sion of anti-Mu ¨llerian hormone (AMH) in Sertoli cells within seminiferous cords (upper panels) and 3b-hydroxysteroid dehydrogenase (3b-HSD)
in Leydig cells in the interstitium (lower panels).
In the top panels, the clear, unstained cytoplasm outlines the nuclei of germ cells within seminiferous cords (inset). Scale bar 50 mm. wks, weeks;
d, days.
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sing VASA, MAGE-A4 or NANOS-1. These investigations
revealed a distinct and only partially overlapping pattern of
expression in germ cell subpopulations in both the marmoset
and human. For example, co-localization of AP-2g with
VASA conﬁrmed our earlier ﬁndings of decreasing proportions
of AP-2g-positive cells and increasing proportions of VASA-
positive cells with increasing age (Fig. 4). In addition, a
small proportion of cells were positive for both proteins at
the same time. Notably, within a single testicular cross
section we detected mixed populations of germ cells within
individual cords, such that a single cord could contain
AP-2g
þ/VASA
2, AP-2g
þ/VASA
þ or AP-2g
2/VASA
þ
germ cells; this pattern was equally evident in the marmoset
and human. The existence of seminiferous cords containing
a germ cell cohort that was predominantly AP-2g
þ/VASA
2
and those that were mostly AP-2g
2/VASA
þ appeared to be
separated by a period of several months in both the marmoset
and the human, and took place from fetal into early postnatal
life. Germ cell expression of these proteins was not synchro-
nized between or within the seminiferous cords of an individual
fetus/neonate and there was also some variation in the timing
of expression between individuals of the same age.
In the marmoset and human a similar expression proﬁle was
demonstrated for OCT4andVASA(Fig. 5), withco-localization
of both proteins in a small proportion of germ cells, resulting
in three different subpopulations, namely OCT4
þ/VASA
2,
OCT4
þ/VASA
þ and OCT4
2/VASA
þ. However in the rat,
there was no evidence for an OCT4
þ/VASA
2 population of
germ cellsand co-localization of OCT4and VASAwas detected
Figure 2: Immunoexpression of pluripotency factors (AP-2g, NANOG, OCT4) that are markers of undifferentiated germ cells (gonocytes) in the
marmoset testis and comparison with the human.
Note that the proportions of germ cells expressing these markers decreases with increasing age. Note also the similar pattern of OCT4 expression
in the marmoset compared to the human. Scale bar 50 mm.
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cells expressed OCT4, but all continued to express VASA
(Fig. 5); the loss of OCT4 immunoexpression appeared to be
synchronous in all germ cells in every cord over this relatively
narrow time period.
Expression of NANOS-1 protein in fetal and postnatal
marmosets and comparison with the human
In the marmoset at 11 weeks’ gestation none of the germ cells
expressed NANOS-1. Increasing proportions of germ cells con-
tained immunopositive staining in their nucleus during the ﬁnal
Figure 3: Immunoexpression of protein markers (MAGE-A4, VASA) of differentiated germ cells (pre-spermatogonia/spermatogonia) in the
marmoset testis and comparison with the human.
Note the increasing proportion of germ cells expressing these markers in the marmoset with increasing age and the similarity with VASA
expression in the human. Scale bar 50 mm.
Figure 4: Distinctionofundifferentiatedgermcells,immunoexpressingAP-2g(red,nuclearlocalization),fromdifferentiatedgermcells,immuno-
expressing VASA (green, cytoplasmic localization), in the marmoset and human perinatal testis using confocal microscopy.
Note that all germ cells are visualized with this combination of markers. A progressive increase with age in the proportion of germ cells expressing
VASAisseenastheproportionofAP-2g-positivegermcellsdecreases.Asmallproportionofgermcellsco-expressedbothmarkers(arrows)andare
presumed to reﬂect a transition state between undifferentiated and differentiated. Sections conterstained with TO-PRO-3 (blue). m, months.
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cells contained NANOS-1, with localization of the protein to
both the nucleus and peri-nuclear cytoplasm (Fig. 6). Human
testes were immunonegative for NANOS-1 in the ﬁrst trimester,
but this protein was expressed in the nucleus of germ cells from
the second trimester onwards with an increasing proportion of
germ cells expressing NANOS-1 as gestation progressed. In
postnatal life, NANOS-1 was also detected in the peri-nuclear
cytoplasm of germ cells. Germ cells immunopositive for
NANOS-1 also expressed VASA (Fig. 6A). However AP-2g
and NANOS-1 were not co-localized (Fig. 6B), which was in
contrast to results obtained for AP-2g and VASA co-staining
(Fig. 4), when a proportion of germ cells were found to be
immunopositive for both proteins. This suggests that expression
of NANOS-1 occurs after VASA expression begins.
Germ cell proliferation in the perinatal marmoset and
human testis and comparison with the rat
Immunoexpression of Ki67 was detected in the marmoset
testis at all fetal ages investigated from 11 weeks’ gestation
until birth, with a reduction in the number of Ki67-positive
germ cells during weeks 15–16 (Fig. 7). Ki67-positive
germ cells were also found in postnatal life, though they
were less frequent than during the majority of fetal life
(Fig. 7). Proliferation occurred in a proportion of both undiffer-
entiated (OCT4-positive, gonocytes) and differentiated (VASA-
positive spermatogonia) germ cells (not shown). In the human
fetal testis, proliferation was seen in a relatively high proportion
of germ cells in the ﬁrst and second trimester, similar to the
proportions seen in the fetal marmoset (not shown). Unfortu-
nately, lack of available good quality tissue prevented us
from accurately determining the germ cell proliferation index
in the third trimester. Previous studies have demonstrated
Ki67 expression in germ cells in the third trimester and into
early postnatal life in the human (Honecker et al., 2004).
Ki67 expression in the rat was high at e15.5 with the majority
of germ cells immunopositive, while at e19.5 none of the germ
cells expressed this protein (Fig. 8).
Germ cell proteins expressed during fetal and early
postnatal life in the human testis were expressed over a
similar age range in germ cells of the marmoset testis (Fig. 9).
Discussion
Despite the similarities that exist between the marmoset and the
human in terms of reproductive biology, little is known about
germ cell differentiation and proliferation in the marmoset.
We have demonstrated that seminiferous cords are present in
the testes of the marmoset at 11 weeks’ gestation and that
there is a similar cellular organization compared with the
human. In addition, germ cell proteins that are known to be
expressed during fetal and early postnatal life in the human
testis were also expressed over a comparable age range in
germ cells of the marmoset testis. In common with the human
we have also demonstrated evidence for mixed subpopulations
of fetal and early postnatal germ cells within individual semini-
ferous cords in the marmoset. Based on our previous data we
believe these represent gonocytes (expressing markers of
pluripotency) and spermatogonia (expressing germ cell-speciﬁc
markers), with an intermediate population that co-express pro-
teins typical of both gonocytes and spermatogonia (Gaskell
et al., 2004). The timing of expression of the germ cell-speciﬁc
proteins during fetal life in the marmoset and human can be con-
sidered in relation to the differences in embryology between
these two species. Fetal life in the marmoset is characterized
by a relatively late implantation and a prolonged embryonic
phase such that the fetal phase, during which most of the
linear growth occurs, begins at 11/20 weeks gestation (Windle
et al., 1999), compared with 7/40 weeks in the human (Phillips,
1976). This may explain why proteins that are ﬁrst expressed in
the human during the second trimester are not expressed in the
marmoset until the ﬁnal third of gestation.
OCT4, a transcription factor and NANOG, a homeobox
domain protein which regulates self-renewal (Hoei-Hansen
et al., 2005), are markers of pluripotency that are expressed
in human gonocytes (Gaskell et al., 2004; Rajpert-De Meyts
et al., 2004). These proteins are expressed in the nuclei of
germ cells within the marmoset testis from fetal into early
postnatal life. Within each seminiferous cord the proportion
of germ cells immunopositive for these proteins decreased as
Figure 5: Comparison of perinatal germ cell differentiation in the
marmoset, human and rat using protein markers of undifferentiated
(OCT4: red, nuclear localization) and differentiated (VASA: green,
cytoplasmic localization) germ cells and confocal microscopy.
Note that in seminiferous cords in both the marmoset and human at
each age studied there is a mixed population of germ cells based on
the expression of these two markers, including occasional cells in
which the markers were co-localized (arrows). This is in contrast to
the rat, in which OCT4 is co-expressed with VASA in all germ cells
at embryonic day 15.5 (e15.5) but was no longer detected within
any of the germ cells at e19.5 (and was largely absent at e17.5, not
shown). wks, weeks.
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human (Looijenga et al., 2003; Gaskell et al., 2004; Honecker
et al., 2004; Rajpert-De Meyts et al. 2004; Kerr et al., 2008)
and conﬁrmed here. Our results, together with previous
reports (Rajpert-De Meyts et al., 2004), show that OCT4 is
still detected in occasional germ cells in the human at 4–6
months postnatally, while NANOG was no longer detected
after 4 weeks. This is in keeping with previous
suggestions of down-regulation of NANOG occurring earlier
in development than OCT4 (Hoei-Hansen et al., 2005).
AP-2g, a DNA binding transcription factor, had a similar
expression proﬁle to OCT4 in germ cells of both the marmoset
and human testis. In the marmoset, only occasional germ cells
expressed this protein by 6 weeks postnatally, whereas in
humans the protein was expressed until 4–6 months of age,
in agreement with previous ﬁndings (Hoei-Hansen et al.,
2004), but in contrast to one report that described no postnatal
expression of this protein (Pauls et al., 2005).
As the proportion of germ cells expressing proteins such as
OCT4, NANOG and AP-2g decreased during gestation in the
marmoset, we found an increase in the proportion of germ
cells expressing germ cell-speciﬁc differentiation markers such
as VASA, a member of the DEAD box family of RNA-binding
proteins (Castrillon et al., 2000) and MAGE-A4, an X-encoded
cancer testis antigen (Gjerstorff et al., 2007). VASA immuno-
positive germ cells were detected from 14 weeks’ gestation in
the marmoset and in an increasing proportion of germ cells as
gestation progressed. In the fetal and early postnatal human
testis the expression proﬁle of these proteins was comparable
to the marmoset, with expression from the second trimester
onwards and the proportion of cells expressing these markers
increasing with age, as has been reported for VASA (Castrillon
et al., 2000) and MAGE-A4 (Aubry et al., 2001; Pauls et al.,
2006), although one study did detect MAGE-A4 in very
occasional germ cells in the ﬁrst trimester (Gaskell et al.,
2004). The frequency of cells expressing VASA during fetal
Figure 6: (A) Comparison of the immunoexpression of NANOS-1 (red, nuclear and cytoplasmic localization) and VASA (green, cytoplasmic
localization) in germ cells in the testis during fetal and postnatal life in the marmoset (top panel) and human (lower panel) using confocal
microscopy.
Note that neither protein is expressed in early gestation in either species but begin to be co-expressed (yellow) in the ﬁnal third of gestation in the
marmoset and in the second trimester in the human testis. In postnatal life, these markers continue to be co-expressed and co-localization in the
peri-nuclear region is seen in most germ cells. (B) Immunoexpression of NANOS-1 (green, nuclear and cytoplasmic localization) and AP-2g (red,
nuclear localization) in the marmoset and human testis for comparison with VASA/AP-2g expression (Fig. 4). NANOS-1 is expressed in most of
the germ cells in the 1-day-old marmoset and 31-week-gestation human testis, with the remainder expressing AP-2g. However, in contrast to
VASA/AP-2g (Fig. 4), no germ cells showed co-localization of NANOS-1 and AP-2g. All sections conterstained with TO-PRO-3 (blue).
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ster onwards in the human (Honecker et al., 2004) or even
reduced from high levels in the second trimester to a stable
level around birth (Cools et al., 2006). However, these studies
involved counting the total number of positive cells rather
than the proportion of positive germ cells at each age.
NANOS-1, an RNA binding protein that is expressed in the
adult human testis (Jaruzelska et al., 2003), is largely conﬁned
to the same germ cells that were immunopositive for VASA. In
both the marmoset and human during fetal life, NANOS-1 was
expressed in the nucleus. In the postnatal testis there was both
nuclear and peri-nuclear cytoplasmic expression. This peri-
nuclear expression of NANOS-1 has been described previously
in human adult germ cells (Jaruzelska et al., 2003). A similar
change in localization within germ cells has been reported
for the RNA-binding protein DAZL, in which the protein is
expressed in the nucleus of ﬁrst trimester germ cells, but is
expressed in both the nucleus and cytoplasm of second trime-
ster germ cells (Anderson et al., 2007). The change in cellular
localization of NANOS-1 suggests that this protein may have
more than one function during germ cell development.
Co-localizationofAP-2g or OCT4 withVASA in the marmo-
set identiﬁed several different subpopulations of immature
germ cells within each cord at any given stage of testicular
development. Most germ cells within a cord expressed a single
protein, however, there was also a population of cells that
expressed both proteins. This suggests that there is a transition
from germ cells expressing AP-2g or OCT4 to germ cells
expressing VASA. Similar subpopulations have also been
described in the human for combinations of markers including
OCT4/VASA (Honecker et al., 2004; Anderson et al., 2007),
Figure 7: (A) Germ cell proliferation in the marmoset testis in fetal and early postnatal life as visualized by immunoexpression of Ki67 (brown)
and (B) as quantiﬁed to generate a proliferation index. Germ cell proliferation (arrows) occurs in a proportion of germ cells throughout fetal (F)
and postnatal life in the marmoset.
At all ages a variable proportion of germ cells are not proliferating (arrowheads). Note that some Sertoli cells are also proliferating in the sections
in A. In (B), bars represent mean+SEM (n ¼ 3 for each age). Scale bar 50 mm.
Figure 8: Germ cell proliferationin the fetal rat testis as visualized by
immunoexpression of the proliferation marker, Ki67 (brown).
Germ cell proliferation (arrows) occurs in the majority of germ cells at
e15.5 but has ceased completely by e19.5 when all germ cells are
negative for Ki67 (arrowhead). Note that, at both ages, some Sertoli
cells (peripherally located) are immunopositive for Ki67. Scale bar
50 mm.
Figure 9: Comparison of germ cell protein expression in the marmo-
set and human from fetal (F) into postnatal life.
The dimensions of the grey bars illustrate the relative proportion of
germ cells expressing an individual marker at a given age.
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AP-2g/MAGE-A4 (Pauls et al., 2006) and these subpopulations
are associated with morphological changes that occur
as gonocytes differentiate into spermatogonia (Fukuda et al.,
1975). We would propose that in the marmoset, as in the
human, the OCT4
þ/VASA
2 germ cells are gonocytes, with
OCT4
þ/VASA
þ cells being intermediate and OCT4
2/
VASA
þ cells representing spermatogonia (Gaskell et al., 2004).
Differentiation of all the germ cells within an individual
seminiferous cord occurred over a relatively long period of
time and in an asynchronous fashion in both the marmoset
and human, such that within a cord during fetal and early post-
natal life, there are often germ cells expressing an early germ
cell marker (e.g. OCT4
þ), a proportion of germ cells only
expressing a later differentiation marker (e.g. VASA) and a
small population of germ cells co-expressing both markers.
Comparison with the rat, using OCT4 and VASA as an
example, demonstrates a clear difference between the rat and
marmoset/human. We have demonstrated that all germ cells
within the fetal rat testis appear to be VASA-positive and
there is no evidence of an OCT4
þ/VASA
2 population, even
at e13.5 before the cords have formed (unpublished obser-
vation). This has also been demonstrated in the mouse, where
VASA is expressed in the germ cells immediately after coloni-
zation of the gonad, but not in migratory primordial germ cells
(Toyooka et al., 2000). In the rat, by e19.5 all of the germ cells
in every cord no longer expressed OCT4 but remained VASA-
positive. Indeed, in most germ cells, switching off of OCT4 is
complete by as early as e17.5 (Ferrara et al., 2006).
In addition to germ cell differentiation, we have also
demonstrated for the ﬁrst time that proliferation of germ cells
occurs in a variable proportion of these cells in the marmoset
during fetal and early postnatal life, and that this proliferation
occurs in germ cells at different stages of differentiation during
this period. Proliferation of germ cells occurs in the human
during the ﬁrst and second trimester and has been reported to
continue in the third trimester and into early postnatal life
(Honecker et al., 2004). In contrast, the rat exhibits a synchro-
nized pattern of germ cell proliferation inwhich a high prolifer-
ation index occurs at e15.5 followed by a complete cessation of
proliferation for the remainder of gestation and until postnatal
Days 4–6 (Ferrara et al., 2006). This proliferative quiescence
covers the period of differentiation of germ cells from gono-
cytes into spermatogonia. A period when testicular germ cell
proliferation has ceased has not been found in the marmoset
or human and proliferation continues to occur during the tran-
sition of germ cells from gonocyte to spermatogonia.
The apparently gradual and asynchronous differentiation and
proliferation of fetal germ cells in the marmoset and human is
intriguing and may have implications regarding the develop-
ment of CIS and TGCT. It is well recognized that CIS cells
(the precursor lesion for TGCT), closely resemble human
fetal germ cells in terms of both morphology (Gondos, 1993)
and protein expression, including NANOG, OCT4, AP-2g,
VASA and MAGE-A4 (Rajpert-De Meyts, 2006). These
expression patterns support the hypothesis that CIS cells arise
from immature fetal germ cells that fail to differentiate comple-
tely into normal spermatogonia (Skakkebaek et al., 1987).
Germ cell differentiation occurs over a prolonged period in
humans and this may, given the right circumstances, predispose
tothe development ofCIS(Rajpert-De Meyts, 2006).Indeed, in
humans with some disorders of sex differentiation there is evi-
dence of delayed germ cell differentiation, based on persistence
of OCT4 expression, in addition to an increased risk of CIS and
TGCT in later life (Cools et al., 2006). The presence of several
subpopulations of germ cells at different stages of differen-
tiation, all exposed to the same local environment within the
seminiferous cords during fetal or early postnatal life may
also increase the likelihood of incomplete differentiation of
some of the more immature germ cells and thus increase the
risk of developing CIS.
In humans, the development of CIS and TGCT has been
proposed to be part of a testicular dysgenesis syndrome (TDS)
(Skakkebaek et al., 2007). A combination of features similar
to human TDS can be induced in the rat using phthalates
(Fisher et al., 2003), but this does not include the development
of CIS or TGCT. This failure to induce CIS in the rodent may
be related to the way in which the fetal germ cells differentiate.
If asynchronous and prolonged differentiation, with several sub-
populationsofgermcellsco-existingindifferentstagesofdiffer-
entiation, predisposes to malignant transformation in the human
(Rajpert-De Meyts, 2006), then CIS may also occur spon-
taneously or be inducible in the marmoset. However, there are
no published reports of testicular tumours in the marmoset,
which could suggest that other predisposing factors may be
required. These factors may include exposure to environmental
factors, such as phthalates. The effect of phthalates on marmoset
germ cell differentiation is currently under investigation.
In summary, we have demonstrated that germ cell differen-
tiation and proliferation in the marmoset is comparable to that
of the human during fetal and early postnatal life. We have also
demonstrated that the process of early germ cell differentiation
takes place over a relatively prolonged period of time and is
asynchronous, resulting in the presence of germ cells at several
stages of differentiation within individual seminiferous cords
during fetal and early postnatal life. In addition, proliferation
occursinavariableproportionofgermcellsthroughoutperinatal
life. This is in marked contrast to the rodent in which more
synchronous germ cell differentiation occurs in late fetal and
early postnatal life, during a relatively narrow time window and
germ cell proliferation completely ceases during late gestation
and early postnatal life. This pattern of germ cell differentiation
and proliferation in the marmoset and human may result
in an increased susceptibility to abnormal/incomplete germ cell
differentiation and conditions that arise from this, such as CIS
and TGCT. Further work is required to establish whether CIS
can be induced in the marmoset.
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